DOI Type of Study Age (yrs) Comorbid conditions COVID 19 severity COVID 19 treatment CMV treatment Outcome
10.12890/2020_001911 Case Report 62 None Severe ARDS Vasoactive drugs, corticosteroids, proning and ECMO Ganciclovir Complete recovery and discharge
10.1136/ bmjgast-2020-000556 Case Report 45-65 None Severe ARDS Remdesivir, Convalescent plasma, systemic hydrocortisone, tocilizumab and ECMO Ganciclovir, Foscarnet for persistent symptoms after excluding drug resistance. Improved and discharged to inpatient skilled nursing facility on TPN and supplemental enteral nutrition.
10.12890/2020_001652 Case Report 92 Diabetes Mellitus and Hypertension Severe ARDS Lopinavir/ritonavir and hydroxychloroquine None Patient passed away from severe respiratory failure
10.1016/j.idcr.2020.e00962 Case Report 68 Hypertension and Glaucoma Severe ARDS Hydroxychloroquine, ECMO, tocilizumab and Remdesivir Intravenous ganciclovir Not mentioned
10.21203/rs.3.rs-52829/v1 Observational Study 60s None Severe ARDS Steroids and ECMO NA Not mentioned
10.11604/pamj.2020.36.167.23922 Case Report 37 NA NA NA None Patient back to his baseline at 2 weeks follow up.
10.4103/jpgm.JPGM_1168_20 Case Report 75 Hypertension Severe ARS Methylprednisolone, hydroxychloroquine, azithromycin, Remdesivir and convalescent plasma. Intravenous ganciclovir Clinical improvement
10.1016/j.idnow.2021.01.005 Retrospective Study Median age 56 Hypertension (47%), Diabetes Mellitus (32%), Diffuse lung disease (38%) Moderate to Severe Lopinavir–Ritonavir, Interferon, Remdesivir, Hydroxychloroquine, Tocilizumab and Corticosteroid Ganciclovir in 2 cases, Valganciclovir in 1 case Pts with CMV viremia were treated successfully with clinical improvement.
10.1002/ccr3.3487 Case Report 42 None Severe ARDS Tocilizumab, hydroxychloroquine, antibiotics, antifungals, and methylprednisolone Ganciclovir Had left hemicolectomy, was discharged to rehab center.
10.1002/ccr3.3600 Case Report 71 Post Tuberculosis aspergilloma Severe covid pneumonia Hydrocortisone Ganciclovir Was discharged from the ICU
10.1016/j.idcr.2021.e01111 Case Report 75 Diabetes Mellitus and Overweight (BMI 26.2) Severe COVID 19 infection dexamethasone, ceftriaxone, spiramycin, oral lopinavir/ritonavir and anakinra oral valganciclovir Underwent recto sigmoidoscopy